BioNTech
BNTX
286 hedge funds and large institutions have $3.3B invested in BioNTech in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 99 reducing their positions, and 36 closing their positions.
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
6% more call options, than puts
Call options by funds: $145M | Put options by funds: $137M
3% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 36
0.21% less ownership
Funds ownership: 17.23% → 17.02% (-0.21%)
0% less funds holding
Funds holding: 287 → 286 (-1)
13% less capital invested
Capital invested by funds: $3.78B → $3.3B (-$487M)
13% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 99
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Flossbach Von Storch
Cologne,
Germany
|
+$83.2M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$67.9M |
| 3 |
Millennium Management
New York
|
+$42.6M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$38.3M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$37.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
-$148M |
| 2 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$81.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$37.7M |
| 4 |
ClearBridge Investments
New York
|
-$33.4M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$30.1M |
BNTX Hedge Fund Activity: Q2 2024 in Review
286 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q2 2024, worth a combined $3.3B — down 13% from $3.78B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new BNTX positions and 36 closed out — a net gain of 1 holder — while 86 added to existing stakes and 99 trimmed.
The largest buyer was Flossbach Von Storch, adding an estimated $83.2M. The largest seller was Temasek Holdings, cutting an estimated $148M.
- 286 institutional investors held BioNTech (BNTX) as of Q2 2024, down from 287 in Q1 2024.
- Funds reported $3.3B of BioNTech stock for Q2 2024, down 13% quarter-over-quarter.
- 37 funds opened new BioNTech positions in Q2 2024 and 36 closed out, a net change of +1 holder.
- The largest BioNTech buyer in Q2 2024 was Flossbach Von Storch, an estimated $83.2M added.
- The largest BioNTech seller in Q2 2024 was Temasek Holdings, an estimated $148M sold.
Based on aggregated 13F filings for Q2 2024.